Through in situ hybridization on 14 prostate tissue samples and quantitative real-time PCR analysis in 25 pairs of matched normal and tumor tissue samples, downregulation of Spry4 in a subset of prostate cancers was reported by Wang et al. [51]. The gene discussed is SPRY4; the disease is Familial prostate cancer.